Cost-Effectiveness Analyses of Natalizumab for 2nd Line Versus Glatiramer Acetate in the Treatment of Relapsing-Remitting Multiple Sclerosis Patients in Brazil

Saved in:

Bibliographic Details
Published in:	Value in health Vol. 16; no. 7; p. A721
Main Authors:	Nishikawa, A.M, Paladini, L, Liamas, A.L, Bueno, C.C, Clark, O.A.C
Format:	Journal Article
Language:	English
Published:	01-11-2013
Subjects:	Internal Medicine
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
ISSN:	1098-3015
DOI:	10.1016/j.jval.2013.08.2248